Scientific Presentations Onvansertib Shows Synergistic Efficacy in Combination with Paclitaxel in HR+ Breast Cancer: Mechanistic Insights from Preclinical Models Click to download Onvansertib Enhances the Anti-tumor Efficacy of Trastuzumab Deruxtecan in Endocrine Therapy- and CDK4/6 Inhibitor-resistant HR+/HER2- Breast Cancer Patient-derived Xenograft Models Click to download A Phase 2, Randomized, Open-label Study of Onvansertib in Combination … Continue reading Scientific Presentations